Covishield

Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine

May 28, 2024 · Atlanta, Georgia Local News

SciCheck Digest A rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This month, the company announced it…

SII stopped Covishield production in Dec 2021, says CEO Adar Poonawalla

October 20, 2022 · Business

Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla, on Thursday said the vaccine manufacturer stopped the production of Covishield vaccine starting December 2021, and of…